Mark Talamonti to Safety-Based Drug Withdrawals
This is a "connection" page, showing publications Mark Talamonti has written about Safety-Based Drug Withdrawals.
Connection Strength
0.403
-
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.
Score: 0.403
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.